Camlin Fine Sciences Ltd — Regulatory Filings 2021

Apr 28, 2021

==> picture [100 x 31] intentionally omitted <==

28[th] April, 2021

To, Surveillance National Stock Exchange of India Ltd ., Exchange Plaza, Bandra Kurla Complex, Bandra (East), Mumbai‐ 400051 Ref: Symbol : CAMLINFINE || Series: EQ

Dear Sir/Madam,

Sub: Increase in Volume

With reference to your letter reference no. NSE/CM/Surveillance/10615 dated April 27, 2021 on the aforesaid subject, please note that the Company has intimated to stock exchanges from time to time all the events, information etc. as per regulation 30 of the SEBI (LODR) Regulations, 2015 that may be having a bearing on the operation/performance of the Company.

We further request you to note that, since the equity shares of the Company are freely traded on the Stock Exchanges, the Company will not be in a position to comment on the movement in the price of the Equity Shares of the Company.

Thanking you,

Yours truly,

For Camlin Fine Sciences Limited,

==> picture [55 x 53] intentionally omitted <==

==> picture [83 x 35] intentionally omitted <==

Mandar Godbole GM Legal, Company Secretary & Compliance Officer

==> picture [426 x 57] intentionally omitted <==